Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients

Applied Immunohistochemistry and Molecular Morphology

Volumn 9, Issue 3, 2001, Pages 267-275

  Ferrero Pous M ^a   Trassard, M ^a   Le Doussal, V ^a   Hacene K ^a   Tubiana Hulin, M ^a   Spyratos, F ^a  

^a Rene Huguenin Hospital   (France)

Author keywords

Breast cancer; Enzyme immunoassay; Estrogen and progesterone receptors; Immunohistochemistry

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; COMPARATIVE STUDY; CORRELATION FUNCTION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; TUMOR VOLUME;

BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0034849122     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200109000-00012     Document Type: Article

References (55)

1. Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer" - 20 years as a target for the treatment and prevention of cancer
2. Steroid hormone receptors in breast cancer management
3. Estrogen and progesterone receptors
4. Mechanism of action of the female sex hormones
5. Estrogen receptor status: An important variable in predicting response to endocrine therapy in metastatic breast cancer
6. Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy
7. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance
8. Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma
9. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival
10. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer
11. Prognostic significance of estrogen receptors in 405 primary breast cancers: A comparison of immunohistochemical and biochemical methods
12. Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: Evaluation of discordant findings
13. Estrogen receptor immunohistochemical assay in paraffin-embedded tissue. A better gold standard?
14. Quantitative immunohistochemical assay for hormonal receptors: Technical aspects and biological significance
15. Immunohistochemical analysis of estrogen receptors in 938 breast carcinomas. Concordance with biochemical assay and prognostic significance
16. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials
17. Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment
18. Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas. A correlative study of 942 cases
19. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information
20. Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in breast carcinoma
21. Immunohistochemical detection of estradiol and progesterone receptors in paraffin sections after treatment with microwaves. Comparison with biochemical assay of receptors in a series of 123 breast cancers with determination of the threshold of optimal positivity
22. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
23. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay
24. Estrogen and progesterone receptors in breast cancer: Comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay
25. A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry
26. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
27. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER)
28. A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples
29. Prognostic and predictive factors in breast cancer by immunohistochemical analysis
30. Oestrogen and progesterone receptors in screen-detected breast carcinoma: An immunohistological study using paraffin sections
31. The world health organization histological typing of breast tumors. 2nd ed.
32. Histological and prognosis in breast carcinomas
33. Localisation anatomique du premier ganglion métastatique du cancer du sein
34. Revision of the standards for the assessment of hormone receptors in human breast cancer
35. Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer
36. Oestrogen receptors: The history, the relevance and the methods of evaluation
37. External evaluation of technical quality of immunohistochemistry. Results of a preliminary multicenter study
38. Recommendations for the immunohistochemistry of the hormonal receptors on paraffin sections in breast cancer. Update 1999
39. Immunocytochemistry
40. Standardization of immunohistochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections
41. Optimizing immunohistochemistry: Antigen retrieval and signal amplification
42. Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients
43. Immunohistochemical analysis of breast carcinoma estrogen and progesterone receptors in paraffinembedded tissue. Correlation of clone ER 1D5 and 1 A 6 with cytosol-based hormone receptor assay
44. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER 1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays
45. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: The need for quality assurance
46. Standardization of estrogen-receptor analysis by immunohistochemistry: An assessment of interlaboratory performance in Ireland
47. A phoenix arisen-estrogen receptor immunohistochemistry
48. Interobserver reproducibility evaluation on steroid receptor immunostaining
49. Determination of oestrogen receptors by enzyme immunoassay
50. Improvement of quality control for steroid receptor measurements: Analysis of distributions in more than 40000 primary breast cancers. French Study Group on Tissue and Molecular Biopathology
51. Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patients
52. Optimization of heat-induced epitope retrieval for estrogen receptor determination by immunohistochemistry on paraffin-sections: Results of a multicentric study
53. Prediction of response to endocrine therapy in breast cancer using immunocytochemical assays for pS2, oestrogen receptor and progesterone receptor
54. Tamoxifen for early breast cancer: An overview of the randomised trials